397 related articles for article (PubMed ID: 26031306)
1. Disintegrins from snake venoms and their applications in cancer research and therapy.
Arruda Macêdo JK; Fox JW; de Souza Castro M
Curr Protein Pept Sci; 2015; 16(6):532-48. PubMed ID: 26031306
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
3. Snake Venom Disintegrins: An Overview of their Interaction with Integrins.
Cesar PHS; Braga MA; Trento MVC; Menaldo DL; Marcussi S
Curr Drug Targets; 2019; 20(4):465-477. PubMed ID: 30360735
[TBL] [Abstract][Full Text] [Related]
4. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
Marcinkiewicz C
Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights of snake venom disintegrins in cancer treatment.
Akhtar B; Muhammad F; Sharif A; Anwar MI
Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Vipera Anatolica Venom Disintegrin via Intracellular Uptake with Radiolabeling Study and Cell-Based Electrochemical Biosensing Assay.
Er O; Eksin E; Soylu HM; Göçmen B; Nalbantsoy A; Yurt F; Erdem A
Appl Biochem Biotechnol; 2019 Apr; 187(4):1539-1550. PubMed ID: 30276529
[TBL] [Abstract][Full Text] [Related]
7. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
8. [Potential use of snake venom components in cancer treatment].
Vivas D; Inga R; Yarlequé A
Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
[TBL] [Abstract][Full Text] [Related]
9. Disintegrins.
McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenesis and RGD-containing snake venom disintegrins.
Swenson S; Ramu S; Markland FS
Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
[TBL] [Abstract][Full Text] [Related]
11. Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.
Lu X; Lu D; Scully MF; Kakkar VV
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):249-60. PubMed ID: 15974889
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
13. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
14. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
[TBL] [Abstract][Full Text] [Related]
15. Non-RGD-containing snake venom disintegrins, functional and structural relations.
Walsh EM; Marcinkiewicz C
Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pancreatic tumoral cells by snake venom disintegrins.
Lucena S; Castro R; Lundin C; Hofstetter A; Alaniz A; Suntravat M; Sánchez EE
Toxicon; 2015 Jan; 93():136-43. PubMed ID: 25450798
[TBL] [Abstract][Full Text] [Related]
18. The continuing saga of snake venom disintegrins.
Calvete JJ
Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
[TBL] [Abstract][Full Text] [Related]
19. Snake venom probes of platelet adhesion receptors and their ligands.
Wijeyewickrema LC; Berndt MC; Andrews RK
Toxicon; 2005 Jun; 45(8):1051-61. PubMed ID: 15922774
[TBL] [Abstract][Full Text] [Related]
20. Recombinant and Chimeric Disintegrins in Preclinical Research.
David V; Succar BB; de Moraes JA; Saldanha-Gama RFG; Barja-Fidalgo C; Zingali RB
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30087285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
